placeholder image
P. Kumar All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC. 
    American Journal of Clinical Oncology. 2014
    • Abstract
  • Variation in care improvement opportunities suggests need for tailored clinician-specific improvement interventions [abstract]. 
    Journal of patient-centered research and reviews. 2019
    • Contact
    full name
  • P. Kumar
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration